Internal + Extramural
Please visit our website to find the complete and updated list of cancer-focused extramural funding opportunities or subscribe to UFHCC Opportunity to receive the weekly email.
Limited Opportunities
NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
Internal Application: 9/24/2022
External | Non-Limited Opportunities
National Cancer Institute (NCI)
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
Application: 11/17/2022
Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional)
Application: 9/30/2022
NCI Outstanding Investigator Award (R35 Clinical Trial Optional)
Application: 11/08/2022; 11/7/2023
Consortium on Translational Research in Early Detection of Liver Cancer: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed)
Required LOI: 10/7/2022
Application: 11/7/2022
Consortium on Translational Research in Early Detection of Liver Cancer: Translational Research Centers (U01 Clinical Trial Optional)
Required LOI: 10/7/2022
Application: 11/7/2022
Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional)
Application: 11/8/2022
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
Application: 11/18/2022
Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required)
Required LOI: 9/28/2022
Application: 10/28/2022; 6/30/2023
Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required)
Required LOI: 9/28/2022
Application: 10/28/2022; 6/30/2023
Cancer Adoptive Cellular Therapy Network (Can-ACT) Coordinating Center (U24 Clinical Trial Not Allowed)
Required LOI: 9/28/2022
Application: 10/28/2022
National Institutes of Health (NIH)
Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional)
Application: 10/5/2022; 2/5/2023; 6/5/2023
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
Application: 10/5/2022; 2/5/2023; 6/5/2023
Biology of Bladder Cancer (R01 Clinical Trial Optional)
Application: 10/5/2022; 2/5/2023; 6/5/2023
Biology of Bladder Cancer (R21 Clinical Trial Optional)
Application: 10/16/2022; 2/16/2023; 6/16/2023
Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed)
Application: 10/27/2022; 7/27/2023
Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed)
Application: 11/3/2022, 5/4/2023
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
Application: 9/6/2022; 1/23/2023
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Required LOI: 9/16/2022
Application: 10/16/2022; 2/16/2022
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
Required LOI: 10/09/2022
Application: 11/09/2022
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
Required LOI: 9/5/2022
Application: 10/5/2022
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
Application: 10/19/2022
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
Application: 10/19/2022
Biomedical Data Repository (U24 – Clinical Trials Not Allowed)
Application: 1/6/2023
Biomedical Knowledgebase (U24 – Clinical Trials Not Allowed)
Application: 9/26/2022
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
Required LOI: 4/24/2023
Application: 5/24/2023
Tobacco Regulatory Science (R01 Clinical Trial Optional)
Required LOI: 12/14/2022
Application: 2/14/2023
Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities
Application: 1/08/2023
HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed) New
Required LOI: 10/14/2022
Application: 11/1/2022
Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)
Required LOI: 1/8/2023
Application:3/8/2023
Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)
Required LOI: 1/8/2023
Application:3/8/2023
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 – Clinical Trial Not Allowed)
Application: 10/05/2022; 2/5/2023
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 – Clinical Trial Optional)
Application: 10/05/2022; 2/5/2023
U.S. Army (DoD) Special Research Programs
Peer Reviewed Cancer Research Program – Behavioral Health Science Award
Required LOI: 9/28/2022
Application: 10/20/2022
Peer Reviewed Cancer Research Program: Career Development Award – Scholar Option
Required LOI: 9/28/2022
Application: 10/20/2022
FY22 Melanoma Research Program (MRP)
Melanoma Academy Scholar Award (MASA)
Required LOI: 9/14/2022
Application: 10/5/2022
Mid-Career Accelerator Award (MCAA)
Required LOI: 9/14/2022
Application: 10/5/2022
Team Science Award (TSA)
Required LOI: 9/14/2022
Application: 10/5/2022
Focused Program Award – Rare Melanomas (FPA)
Required LOI: 9/14/2022
Application: 10/5/2022
FY22 Kidney Cancer Research Program (KCRP)
Academy of Kidney Cancer Investigators Early-Career Scholar Award (AKCIECSA)
Required LOI: 9/29/2022
Application: 10/20/2022
Nurse-Initiated Research Award (NIRA)
Required LOI: 9/29/2022
Application: 10/20/2022
Clinical Trial Award (CTA)
Required LOI: 9/29/2022
Application: 10/20/2022
FY22 Breast Cancer Research Program (BCRP)
Breakthrough Award Levels 1 and 2 II (BTA12-2)
Required LOI: 9/22/2022
Application: 10/6/2022
Era of Hope Scholar Award II (EOHS-2)
Required LOI: 9/22/2022
Application: 10/6/2022
Peer-Reviewed Agencies
Howard Hughes Medical Institute
Freeman Hrabowski Scholars Program
Application: 9/28/2022
Melanoma Research Foundation
Mid-Career Bridge Grant Request for Proposals (RFP)
Application: 12/15/2022
MRA General RFP
Required LOI: 10/5/2022
Application: 11/2/2022
American Association for Cancer Research (AACR)
AACR-NOVOCURE Career Development Award for Tumor Treating Fields Research in Ovarian Cancer
Application: 9/20/2022
AACR-Novocure Tumor Treating Fields in NSCLC Research Grant
Application: 9/20/2022
Alex’s Lemonade Stand Foundation (ALSF)
2023 Innovation Grant
LOI: 10/11/2022
2023 Young Investigator Grant
Application: 12/12/2022
Non-Peer Reviewed Agencies
The Mike Slive Foundation
2022 Grant Program
Application: 10/1/2022
Foundation for Women’s Cancer (FWC) / Society of Gynecologic Oncology
National Ovarian Cancer Coalition Early Detection Research Grant
Abstract: 9/6/2022
Application: 10/1/2022
Rally Foundation for Childhood Cancer Research
Young Investigator and Independent Investigator Grants
Required LOI: 9/23/2022
Fellowship Grant
Required LOI: 9/3/2022
American Lung Association (ALA)
Lung Cancer Discovery Award
Required LOI: 9/15/2022
Application: 12/15/2022
Innovation Award
Application: 12/15/2022
Public Policy Research Award
Application: 12/15/2022
Catalyst Award
Application: 12/15/2022
Curing Kids Cancer
Individual Grant
Application: 10/10/2022
Multi-institutional Collaborative Grant
Application: 10/10/2022
American Gastroenterological Association (AGA)
AGA-Gastric Cancer Foundation Ben Feinstein Memorial Research Scholar Award in Gastric Cancer
Application: 11/9/2022
Gateway for Cancer Research
GFCR Grant Program
Application: 11/1/2022
NCI/SPORE Program
Application: 11/1/2022
Cancer Research Institute
Technology Impact Award
Required LOI: 11/15/2022
Application: 3/15/2022
Clinic & Laboratory Integration Program (CLIP)
Required LOI: 12/1/2022
Application: 3/1/2023
Pfizer Inc.
Immunotherapy in High-risk Non-Muscle Invasive Bladder Cancer
Application: 9/21/2022
Lung Cancer Foundation of America
LCFA/BMS/ILCF Disparities in Clinical Oncology Research Grants in Translational Immuno-oncology
Application: 2/28/2023
California Breast Cancer Research Program
Innovative, Developmental, and Exploratory Awards (IDEA)
Required LOI: 10/20/2022
Application: 3/2/2023
Translational Research Award
Required LOI: 10/20/2022
Application: 3/2/2023
Tower Cancer Research Foundation
Senior Investigator Grant
Application: 10/14/2022
Career Development Award
Application: 10/14/2022
ChadTough Defeat DIPG Foundation
Fellowship grant
Application: 9/16/2022
New Investigator
Application: 2/9/2023
Game Changer
Application: 2/9/2023
Other External
Diversity, equity, and inclusion funding opportunities
Cancer Research Foundation
National Cancer Institute (NCI)
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
Deadline: 9/6/22
NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)
Deadline: 10/12/22
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required)
Deadline: 10/12/22
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)
Deadline: 10/12/22
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
Deadline: 10/12/22
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
Deadline: 11/17/22
Notice of Special Interest (NOSI): Administrative Supplements to Support Germline Genome-wide Genotyping and Sequencing of Existing Samples from Minority Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data
Deadline: Dependent upon mechanism
Notice of Special Interest: Alcohol and Cancer Control
Deadline: Dependent upon mechanism
National Institutes of Health (NIH)
T32 Training Program for Institutions That Promote Diversity (T32 – Clinical Trial Not Allowed)
Deadline: 9/13/22
NLM Information Resource Grants to Reduce Health Disparities (G08 Clinical Trial Not Allowed)
LOI: 9/21/22; Application: 10/21/22
Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional)
Deadline: 10/5/22
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required)
Deadline: 10/13/22
Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed)
Deadline: 10/27/22
Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 – Clinical Trials Optional)
Deadline: 11/13/22
Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)
Deadline: 11/17/22
Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
Deadline: 1/26/23
Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed)
Deadline: 2/5/23
Notice of Special Interest: NIDCD Health Disparities and Inequities Research
Deadline: Dependent upon mechanism
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects
Deadline: Dependent upon mechanism
Notice of Special Interest: Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)
Deadline: Dependent upon mechanism
American Society of Clinical Oncology (ASCO)
Advanced Clinical Research Award (ACRA) for Diversity and Inclusion
Deadlines: 12/14/22 | 1/31/23
William T. Grant Foundation
Institutional Challenge Grant
Deadline: 9/14/22